Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)
Japan
· Delayed Price · Currency is JPY 5,673.00
-90.00 (-1.56%)
Jan 20, 2025, 3:30 PM JST
Kobayashi Pharmaceutical Revenue
Kobayashi Pharmaceutical had revenue of 41.32B JPY in the quarter ending September 30, 2024, a decrease of -9.16%. This brings the company's revenue in the last twelve months to 168.80B, down -1.34% year-over-year. In the year 2023, Kobayashi Pharmaceutical had annual revenue of 173.46B with 4.33% growth.
Revenue (ttm)
168.80B
Revenue Growth
-1.34%
P/S Ratio
2.50
Revenue / Employee
47.76M
Employees
3,534
Market Cap
421.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | 150.51B | -17.54B | -10.44% |
| Dec 31, 2019 | 168.05B | 573.00M | 0.34% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Japan Tobacco | 3,077.34B |
| Seven & i Holdings | 10.34T |
| Ajinomoto Co. | 1,495.48B |
| Kao Corporation | 1,596.71B |
| Pan Pacific International Holdings | 2,136.34B |
| Asahi Group Holdings | 2,914.04B |
| Unicharm | 976.41B |
| Kirin Holdings Company | 2,286.24B |